Concepts (86)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| United States Department of Veterans Affairs | 4 | 2024 | 707 | 0.920 |
Why?
|
| Mental Health Services | 2 | 2024 | 278 | 0.900 |
Why?
|
| Professional Role | 1 | 2024 | 72 | 0.860 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2024 | 138 | 0.800 |
Why?
|
| Attitude of Health Personnel | 2 | 2024 | 717 | 0.750 |
Why?
|
| Anxiety Disorders | 2 | 2024 | 734 | 0.720 |
Why?
|
| Telemedicine | 2 | 2024 | 500 | 0.640 |
Why?
|
| Health Personnel | 1 | 2024 | 541 | 0.630 |
Why?
|
| Registries | 1 | 2024 | 1577 | 0.550 |
Why?
|
| Mental Disorders | 1 | 2022 | 887 | 0.460 |
Why?
|
| Qualitative Research | 4 | 2024 | 638 | 0.430 |
Why?
|
| Veterans | 3 | 2024 | 1782 | 0.280 |
Why?
|
| Burns | 1 | 2024 | 100 | 0.210 |
Why?
|
| United States | 5 | 2024 | 11748 | 0.200 |
Why?
|
| Interviews as Topic | 1 | 2024 | 420 | 0.200 |
Why?
|
| Quantum Dots | 1 | 2022 | 14 | 0.200 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 1 | 2022 | 32 | 0.200 |
Why?
|
| Videoconferencing | 1 | 2022 | 22 | 0.200 |
Why?
|
| Mental Health | 2 | 2023 | 373 | 0.190 |
Why?
|
| Microscopy, Electron | 1 | 2022 | 367 | 0.190 |
Why?
|
| Implosive Therapy | 1 | 2024 | 98 | 0.190 |
Why?
|
| Mentoring | 1 | 2023 | 82 | 0.180 |
Why?
|
| Feasibility Studies | 1 | 2024 | 820 | 0.180 |
Why?
|
| Firearms | 1 | 2021 | 57 | 0.170 |
Why?
|
| Cell Membrane | 1 | 2022 | 489 | 0.170 |
Why?
|
| Wounds, Gunshot | 1 | 2021 | 147 | 0.170 |
Why?
|
| Cancer Survivors | 1 | 2023 | 248 | 0.170 |
Why?
|
| Psychotherapy | 1 | 2022 | 246 | 0.160 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2022 | 507 | 0.160 |
Why?
|
| HIV-1 | 1 | 2022 | 488 | 0.150 |
Why?
|
| Exercise | 1 | 2024 | 870 | 0.150 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2024 | 905 | 0.140 |
Why?
|
| Clinical Competence | 1 | 2024 | 1061 | 0.140 |
Why?
|
| Trichechus manatus | 1 | 2017 | 1 | 0.140 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2017 | 50 | 0.130 |
Why?
|
| Complementarity Determining Regions | 1 | 2017 | 26 | 0.130 |
Why?
|
| Depression | 1 | 2024 | 1362 | 0.120 |
Why?
|
| Aquaculture | 1 | 2014 | 9 | 0.120 |
Why?
|
| Penaeidae | 1 | 2014 | 5 | 0.120 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2024 | 828 | 0.120 |
Why?
|
| Seafood | 1 | 2014 | 10 | 0.120 |
Why?
|
| Humans | 11 | 2024 | 134059 | 0.110 |
Why?
|
| Surveys and Questionnaires | 1 | 2024 | 3999 | 0.110 |
Why?
|
| Middle Aged | 3 | 2024 | 29399 | 0.080 |
Why?
|
| Adult | 3 | 2024 | 31961 | 0.080 |
Why?
|
| Neoplasms | 1 | 2023 | 3034 | 0.070 |
Why?
|
| Transcriptome | 1 | 2014 | 1137 | 0.070 |
Why?
|
| Pandemics | 2 | 2023 | 1190 | 0.060 |
Why?
|
| Male | 3 | 2024 | 66045 | 0.050 |
Why?
|
| Female | 3 | 2024 | 71845 | 0.050 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2024 | 228 | 0.050 |
Why?
|
| Cell-Penetrating Peptides | 1 | 2022 | 2 | 0.050 |
Why?
|
| Patients | 1 | 2023 | 127 | 0.050 |
Why?
|
| Behavior Therapy | 1 | 2024 | 268 | 0.050 |
Why?
|
| Medical Oncology | 1 | 2023 | 247 | 0.050 |
Why?
|
| Personal Satisfaction | 1 | 2022 | 106 | 0.050 |
Why?
|
| Interpersonal Relations | 1 | 2023 | 229 | 0.050 |
Why?
|
| Safety | 1 | 2021 | 217 | 0.040 |
Why?
|
| Quality of Health Care | 1 | 2023 | 420 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2024 | 1492 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2022 | 399 | 0.040 |
Why?
|
| Nanoparticles | 1 | 2022 | 290 | 0.040 |
Why?
|
| Ambulatory Care | 1 | 2022 | 415 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2024 | 1217 | 0.040 |
Why?
|
| Antibody Diversity | 1 | 2017 | 9 | 0.030 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2017 | 19 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2022 | 649 | 0.030 |
Why?
|
| Immunity, Humoral | 1 | 2017 | 76 | 0.030 |
Why?
|
| Primary Health Care | 1 | 2022 | 803 | 0.030 |
Why?
|
| Mammals | 1 | 2017 | 280 | 0.030 |
Why?
|
| Biological Evolution | 1 | 2017 | 256 | 0.030 |
Why?
|
| Daphnia | 1 | 2014 | 3 | 0.030 |
Why?
|
| Crustacea | 1 | 2014 | 7 | 0.030 |
Why?
|
| Parents | 1 | 2021 | 1070 | 0.030 |
Why?
|
| Immune System | 1 | 2014 | 98 | 0.030 |
Why?
|
| Quality of Life | 1 | 2024 | 2157 | 0.030 |
Why?
|
| User-Computer Interface | 1 | 2014 | 167 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2017 | 710 | 0.030 |
Why?
|
| DNA Replication | 1 | 2014 | 364 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2014 | 500 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2014 | 426 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2024 | 13048 | 0.020 |
Why?
|
| Algorithms | 1 | 2014 | 1736 | 0.020 |
Why?
|
| Genomics | 1 | 2014 | 1669 | 0.020 |
Why?
|
| Animals | 2 | 2017 | 36539 | 0.010 |
Why?
|
| Child | 1 | 2021 | 25839 | 0.010 |
Why?
|